Future of the pharmacogenomics of calcineurin inhibitors in renal transplant patients

被引：6
|
作者：
Zhu, Huaijun [1 ]
Ge, Weihong [1 ]
机构：
[1] Nanjing Univ, Affiliated Nanjing Drum Tower Hosp, Sch Med, Dept Pharm, Nanjing 210008, Jiangsu, Peoples R China
来源：
PHARMACOGENOMICS | 2011年 / 12卷 / 11期
关键词：
calcineurin inhibitor; epigenetics; orphan nuclear receptor; pharmacogenomics; renal transplantation; REGULATED GENE-EXPRESSION; RECIPIENTS; THERAPY; PHARMACOKINETICS; PHARMACODYNAMICS; PERSPECTIVES; CELLS; CYP3A;
D O I：
10.2217/PGS.11.129
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1505 / 1508
页数：4
相关论文
共 50 条
  • [21] Genes and beans: pharmacogenomics of renal transplant
    Murray, Brian
    Hawes, Emily
    Lee, Ruth-Ann
    Watson, Robert
    Roederer, Mary W.
    PHARMACOGENOMICS, 2013, 14 (07) : 783 - 798
  • [22] Comparative Study of the Cellular Pharmacodynamics of Calcineurin Inhibitors Between Patients With Chronic Renal Failure Awaiting Renal Transplantation and Cirrhosis Patients Awaiting Liver Transplantation
    Kihara, Yu
    Matsuno, Naoto
    Mijiti, Abuduxukuer
    Nagao, Takeshi
    Takeuchi, Hironori
    Unezaki, Sakae
    Hirano, Toshihiko
    CELL TRANSPLANTATION, 2009, 18 (5-6) : 639 - 646
  • [23] Systematic review and meta-analysis of calcineurin inhibitors on long-term prognosis of renal transplant patients
    Yang, Kang
    Zhang, Meiling
    Zhang, Beining
    Zhang, Yingshi
    Zhao, Qingchun
    TRANSPLANT IMMUNOLOGY, 2022, 75
  • [24] Effects of calcineurin inhibitors on sirolimus pharmacokinetics during staggered administration in renal transplant recipients
    Wu, FLL
    Tsai, MK
    Chen, RRL
    Sun, SW
    Huang, JD
    Hu, RH
    Chen, KH
    Lee, PH
    PHARMACOTHERAPY, 2005, 25 (05): : 646 - 653
  • [25] Calcineurin-Inhibitor Minimization in Liver Transplant Patients with Calcineurin-Inhibitor-Related Renal Dysfunction: A Meta-Analysis
    Kong, Yuan
    Wang, Dongping
    Shang, Yushu
    Liang, Wenhua
    Ling, Xiaoting
    Guo, Zhiyong
    He, Xiaoshun
    PLOS ONE, 2011, 6 (09):
  • [26] Correlation between gene polymorphism and blood concentration of calcineurin inhibitors in renal transplant recipients An overview of systematic reviews
    Su, Lan
    Yin, Lu
    Yang, Jinkun
    Sun, Lin
    MEDICINE, 2019, 98 (26)
  • [27] Assessing the Metabolic Effects of Calcineurin Inhibitors in Renal Transplant Recipients by Urine Metabolic Profiling
    Dieme, Binta
    Halimi, Jean Michel
    Emond, Patrick
    Buechler, Matthias
    Nadal-Desbarat, Lydie
    Blasco, Helene
    Le Guellec, Chantal
    TRANSPLANTATION, 2014, 98 (02) : 195 - 201
  • [28] A numerical scale comparison of renal transplant recipient experience with and opinions about calcineurin inhibitors
    Prasad, GVR
    Nash, MM
    McFarlane, PA
    Zaltzman, JS
    NEPHRON CLINICAL PRACTICE, 2004, 97 (02): : C35 - C40
  • [29] Long-term results in renal transplant patients with allograft dysfunction after switching from calcineurin inhibitors to sirolimus
    Bumbea, V
    Kamar, N
    Ribes, D
    Esposito, L
    Modesto, A
    Guitard, J
    Nasou, G
    Durand, D
    Rostaing, L
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 (11) : 2517 - 2523
  • [30] Influence of conversion from calcineurin inhibitors to everolimus on fibrosis, inflammation, tubular damage and vascular function in renal transplant patients
    Alpay, Nadir
    Ozkok, Abdullah
    Caliskan, Yasar
    Akagun, Tulin
    Cinar, Suzan Adin
    Deniz, Gunnur
    Sariyar, Muzaffer
    Yildiz, Alaattin
    CLINICAL AND EXPERIMENTAL NEPHROLOGY, 2014, 18 (06) : 961 - 967
12345